Director/PDMR Shareholding.


    10 June 2025 23:11:44
  • Source: Sharecast
RNS Number : 2641M
NatWest Group plc
10 June 2025
 

10 June 2025

NatWest Group plc

 

  

INITIAL NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY (PDMRs) IN ACCORDANCE WITH ARTICLE 19 OF THE MARKET ABUSE REGULATION

 

1.  NatWest Group plc (the Company) announces that deferred awards over ordinary shares of £1.0769* each in the Company (Shares) (ISIN: GB00BM8PJY71) vested on 9 June 2025, under the NatWest Group plc 2024 Employee Share Plan (the Plan), to the PDMRs set out below. The awards were granted under the Plan on 7 March 2025.

 

The number of Shares withheld to meet associated tax liabilities arising on vesting and the number of vested Shares retained by each PDMR are set out below.

 

Name of PDMR

Position of PDMR

No. of Shares vested

No. of Shares withheld to satisfy associated tax liability

 

No. of vested Shares retained

 

Robert Begbie

 

CEO, NatWest Commercial & Institutional

50,812

25,445

25,367

Angela Byrne

Interim CEO, Retail Banking

24,536

11,550

12,986

Emma Crystal

CEO, Coutts and Wealth Businesses

44,305

20,855

23,450

Keiran Foad

 

Group Chief Risk Officer

 

57,339

26,990

30,349

Scott Marcar

 

Group Chief Information Officer

 

65,761

30,955

34,806

Katie Murray

Group Chief Financial Officer

65,375

30,773

34,602

 

Paul Thwaite

 

Group Chief Executive Officer

97,215

45,760

51,455

 

Jen Tippin

 

Group Chief Operating Officer

 

65,701

30,926

34,775

 

The market price used to meet associated tax liabilities was £5.2605. 

 

Vested Shares retained after payment of associated tax liabilities will be subject to a twelve-month retention period. 

 

2.  The Company announces that the PDMR set out below has sold Shares on the date and at the price indicated:

Name of PDMR

Position of PDMR

No. of Shares sold

Sale price

Date of transaction

Robert Begbie

CEO, NatWest Commercial & Institutional

100,000

£5.2106

10 June 2025

 

 

All of the above transactions took place on the London Stock Exchange (XLON).

 

* Note: the nominal value of ordinary shares without rounding is £1.076923076923077 per share 

 

Legal Entity Identifier: 2138005O9XJIJN4JPN90

 

For further information contact:

NatWest Group Investor Relations
Claire Kane
Director of Investor Relations
+44 20 7672 1758

 

NatWest Group Media Relations 

+44(0)131 523 4205

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSFWFISEISESM

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.